Search

everythinglearnresearchcommunity

for

Search:↓

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

SHBG may be a useful early indicator and treatment target for PCOS.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Androgens can both increase and decrease hair growth in different parts of the body.

Androgen use may increase the risk of stroke, but more research is needed.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Finasteride for hair loss may cause gynecomastia; doctors should inform patients.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Early NAS level changes affect alcohol consumption vulnerability.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Changing neuroactive steroids in baby male rats affects their memory and learning differently as they grow up.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Certain drugs change freshwater snail shells to a "banana" shape.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.